RBC Europe’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $8K | Sell |
130
-200
| -61% | -$12.3K | ﹤0.01% | 523 |
|
|
2022
Q1 | $21K | Hold |
330
| – | – | ﹤0.01% | 447 |
|
|
2021
Q4 | $18K | Sell |
330
-7,728
| -96% | -$422K | ﹤0.01% | 470 |
|
|
2021
Q3 | $569K | Hold |
8,058
| – | – | 0.02% | 189 |
|
|
2021
Q2 | $537K | Sell |
8,058
-868
| -10% | -$57.8K | 0.02% | 195 |
|
|
2021
Q1 | $991K | Sell |
8,926
-411
| -4% | -$45.6K | 0.05% | 140 |
|
|
2020
Q4 | $1.11M | Hold |
9,337
| – | – | 0.06% | 131 |
|
|
2020
Q3 | $815K | Sell |
9,337
-340
| -4% | -$29.7K | 0.05% | 137 |
|
|
2020
Q2 | $867K | Hold |
9,677
| – | – | 0.07% | 130 |
|
|
2020
Q1 | $964K | Sell |
9,677
-973
| -9% | -$97K | 0.1% | 105 |
|
|
2019
Q4 | $1.22M | Hold |
10,650
| – | – | 0.11% | 107 |
|
|
2019
Q3 | $1.34M | Hold |
10,650
| – | – | 0.13% | 101 |
|
|
2019
Q2 | $1.28M | Hold |
10,650
| – | – | 0.13% | 105 |
|
|
2019
Q1 | $932K | Hold |
10,650
| – | – | 0.1% | 113 |
|
|
2018
Q4 | $1.07M | Hold |
10,650
| – | – | 0.14% | 97 |
|
|
2018
Q3 | $1.22M | Sell |
10,650
-69
| -0.6% | -$7.91K | 0.14% | 107 |
|
|
2018
Q2 | $961K | Sell |
10,719
-250
| -2% | -$22.4K | 0.11% | 114 |
|
|
2018
Q1 | $802K | Sell |
10,969
-500
| -4% | -$36.6K | 0.1% | 122 |
|
|
2017
Q4 | $666K | Hold |
11,469
| – | – | 0.08% | 134 |
|
|
2017
Q3 | $515K | Buy |
+11,469
| New | +$515K | 0.07% | 149 |
|